Press Releases

Current Articles | Categories | Search | Syndication

11 April 2014  Rachel Myers
Breakthrough technology to enable doctors to select more effective treatment for cancer patients on a personalised basis.
By Rachel Myers @ 15:17 :: 64 Views



11th April 2014, Cobham, UK. -- The possibility of patients with pancreatic cancer being able to have their cancer tissue ‘profiled’ to understand how they will react to different treatments before they are given to them has moved a lot closer, a new research paper shows, published in the peer reviewed journal PLOS ONE. This will enable more accurate profiling and the best drug selection for each individual. Trials are being planned to undertake the final stage of the process. 

Read More

08 April 2014  Rachel Myers
Siemens Healthcare Diagnostics leads the way with standardisation of Vitamin D assay
By Rachel Myers @ 11:03 :: 77 Views



Siemens Healthcare Diagnostics has become the first manufacturer to gain standardisation of its ADVIA Centaur® Vitamin D Total assay to the National Institute of Standards and Technology - Ghent University Reference Measurement Procedure based on isotope-dilution liquid chromatography-tandem mass spectrometry. 

Read More

02 April 2014  Rebecca Bellars
EKF Diagnostics has acquired Separation Technology
By Rebecca Bellars @ 16:16 :: 114 Views



EKF Diagnostics (www.ekfdiagnostics.com), the global in vitro diagnostics business, announces that it has acquired Separation Technology, Inc. (STI), the Florida based manufacturer of in vitro diagnostics devices for hematology testing. 

Read More

01 April 2014  Joanne Hunter
Coming out of the Cold with Stat-Nat® Thermally Stable PCR Master Mix
By Joanne Hunter @ 10:48 :: 126 Views


Now available in the UK from Alpha Laboratories (Eastleigh, Hants), STAT-NAT® is a new protective compound that stabilises the activity of enzymes for a very long time with no temperature controlled storage requirements. This proprietary technology developed by Sentinel (Milan, Italy), provides an optimal and convenient basic platform useful for kits, “home brew” routine tests, and for the development of new assays.

Read More

27 March 2014  Joanne Hunter
SysQuant® - Pancreatic Cancer Study in PLOS ONE
By Joanne Hunter @ 10:56 :: 133 Views

27th March, 2014 – The SysQuant® study addressing pancreatic cancer published yesterday in PLOS ONE provides a helicopter view over cell signalling pathways that elegantly demonstrates Proteome Sciences ability to measure the phosphorylation status and expression of very important drug targets and many other signalling proteins. This technology is equally applicable to all cancers. With our collaborators at King’s College Hospital, London SysQuant® identified a number of novel potential therapeutic targets and new diagnostic and prognostic biomarkers covered by patent applications.

Read More

26 March 2014  Joanne Hunter
Liver disease - simple test available could save lives says expert
By Joanne Hunter @ 15:20 :: 139 Views


Please find below industry commentary from Siemens Healthcare responding to the report from the all-party Parliamentary Hepatology Group outlining how deaths from liver disease in England have risen by 40% between 2001-2012:

Read More

26 March 2014  Joanne Hunter
AACR 2014 – EKF Molecular Highlights Ultra-Sensitive Cancer Mutation Detection Kits
By Joanne Hunter @ 08:41 :: 181 Views

Cardiff, UK – 25th March 2014 – EKF Diagnostics (www.ekfdiagnostics.com), the global in vitro diagnostics business, will be present on Booth #438 at AACR 2014 (American Association of Cancer Research), 5-9th April, San Diego. EKF Molecular will exhibit its PointMan™ DNA-enrichment technology which enables ultra-sensitive and highly-specific cancer mutation detection unmatched by existing technologies.

Read More

25 March 2014  Joanne Hunter
Siemens shares future developments and intelligence around Free Light Chains with BN customers
By Joanne Hunter @ 14:29 :: 150 Views

Siemens Healthcare Diagnostics recently held a BN™II and BN ProSpec® Customer Connection Event in Birmingham, providing delegates with updates on the latest developments and tools available. The two-day event attracted customers using the plasma protein systems from all across the UK and provided an opportunity to interact with colleagues and Siemens experts to share experience and best practice.

Read More

25 February 2014  Joanne Hunter
HORIBA Medical Launches Compact Multifunctional Haematology Analyser
By Joanne Hunter @ 09:38 :: 247 Views


Northampton, UK– 24th February 2014 – HORIBA UK Ltd, Medical Division
, has launched the new Pentra XLR compact 5 part DIFF haematology analyser incorporating full reticulocyte parameters to facilitate the investigation and diagnosis of haemopoiesis and anaemia. As the latest addition to the Pentra family, the XLR brings HORIBA’s gold standard reticulocyte technology with STAT capabilities to a smaller platform. This makes it ideal for space-restricted laboratories or those with a smaller workload that do not want to compromise on quality.

Read More

25 February 2014  Joanne Hunter
PLACING TO RAISE £5 MILLION
By Joanne Hunter @ 09:14 :: 260 Views


24th February 2014, Cobham, UK – Proteome Sciences plc (“Proteome Sciences” or the “Company”) is pleased to announce that it has conditionally placed 17,857,143 new ordinary shares of 1p each (“New Ordinary Shares”) to raise £5 million before expenses with new and existing investors (the “Placing”) at 28p per share (the “Placing Price”) to provide additional working capital for the Company. Christopher Pearce, Chief Executive of the Proteome Sciences, has subscribed for 3,571,429 New Ordinary Shares in the Placing at the Placing Price. Following this transaction Christopher Pearce will hold 35,109,504 ordinary shares in the Company representing 16.4 per cent. of the Company’s enlarged share capital.

Read More

Previous Page | Next Page